ConductScience.org, home

Paper40429403

Inefficiency Rates of Biological Immunosuppressive Induction Agents Used in Organ Transplantation: A Pharmacovigilance Study.

Butuca A and 10 others. J Clin Med, 2025. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Inefficiency Rates of Biological Immunosuppressive Induction Agents Used in Organ Transplantation: A Pharmacovigilance Study. Papers, record 40429403. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40429403

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Inefficiency Rates of Biological Immunosuppressive Induction Agents Used in Organ Transplantation: A Pharmacovigilance Study.
PubMed
Journal
J Clin Med
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2025-05-31
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Butuca AAncahttps://orcid.org/0000-0003-1540-641X
2Stoicescu LLaurentiuhttps://orcid.org/0000-0001-7451-1901
3Popa MLMirela Livia
4Dobrea CMCarmen Maximilianahttps://orcid.org/0000-0002-9913-1750
5Muntean AAdriana
6Morgovan CClaudiuhttps://orcid.org/0000-0003-2730-8729
7Pienar CCorina
8Gligor FGFelicia Gabrielahttps://orcid.org/0000-0003-3167-9864
9Ghibu SStelianahttps://orcid.org/0000-0003-2247-4613
10Popa Ilie IRIoana Radahttps://orcid.org/0000-0002-5281-5004
11Frum AAdinahttps://orcid.org/0000-0003-4874-0430

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
LBUS-IRG-2023 No. 3536/24.07.2023Lucian Blaga University of SibiuPubMed

Source PubMed

Download CSV of grants

References56

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
135497810Thymoglobulin Versus Alemtuzumab Versus Basiliximab Kidney Transplantation From Donors After Circulatory Death.Kidney Int Rep2022https://conductscience.org/library/papers/35497810PubMed
238020744A Decade of Experience With Alemtuzumab Therapy for Severe or Glucocorticoid-Resistant Kidney Transplant Rejection.Transpl Int2023https://conductscience.org/library/papers/38020744PubMed
336819125Very Low Dose Anti-Thymocyte Globulins Versus Basiliximab in Non-Immunized Kidney Transplant Recipients.Transpl Int2023https://conductscience.org/library/papers/36819125PubMed
432404066Low-dose alemtuzumab induction in a tailored immunosuppression protocol for sensitized kidney transplant recipients.BMC Nephrol2020https://conductscience.org/library/papers/32404066PubMed
534620231Descriptive analysis of adverse drug reaction reports in children and adolescents from Germany: frequently reported reactions and suspected drugs.BMC Pharmacol Toxicol2021https://conductscience.org/library/papers/34620231PubMed
637793748Outcomes of Heart Transplant Donation After Circulatory Death.J Am Coll Cardiol2023https://conductscience.org/library/papers/37793748PubMed
735720296Induction Strategies in Lung Transplantation: Alemtuzumab vs. Basiliximab a Single-Center Experience.Front Immunol2022https://conductscience.org/library/papers/35720296PubMed
817093248Rabbit antithymocyte globulin versus basiliximab in renal transplantation.N Engl J Med2006https://conductscience.org/library/papers/17093248PubMed
934697664Immunosuppression and Kidney Transplantation.Handb Exp Pharmacol2022https://conductscience.org/library/papers/34697664PubMed
1038665475European Consensus on the Management of Sensitized Kidney Transplant Recipients: A Delphi Study.Transpl Int2024https://conductscience.org/library/papers/38665475PubMed
1125563998Pancreas transplant alone.Curr Opin Organ Transplant2015https://conductscience.org/library/papers/25563998PubMed
1236986554A Descriptive Analysis of Direct Oral Anticoagulant Drugs Dosing Errors Based on Spontaneous Reports from the EudraVigilance Database.Pharmaceuticals (Basel)2023https://conductscience.org/library/papers/36986554PubMed
1333428661Comparison of alemtuzumab, anti-thymocyte globulin, and post-transplant cyclophosphamide for graft-versus-host disease and graft-versus-leukemia in murine models.PLoS One2021https://conductscience.org/library/papers/33428661PubMed
1432719676Comparison of Alemtuzumab and Anti-thymocyte Globulin Treatment for Acute Kidney Allograft Rejection.Front Immunol2020https://conductscience.org/library/papers/32719676PubMed
1531405369Adverse events with fatal outcome associated with alemtuzumab treatment in multiple sclerosis.BMC Res Notes2019https://conductscience.org/library/papers/31405369PubMed
1628434523Belatacept: Where the BENEFITS Outweigh the Risk.Am J Kidney Dis2017https://conductscience.org/library/papers/28434523PubMed
1731649071Sex Differences in Kidney Replacement Therapy Initiation and Maintenance.Clin J Am Soc Nephrol2019https://conductscience.org/library/papers/31649071PubMed
1838790915Safety Profile of the Trastuzumab-Based ADCs: Analysis of Real-World Data Registered in EudraVigilance.Biomedicines2024https://conductscience.org/library/papers/38790915PubMed
1932436821Immunosuppression in Kidney Transplantation: State of the Art and Current Protocols.Curr Pharm Des2020https://conductscience.org/library/papers/32436821PubMed
2019424038Rabbit antithymocyte globulin is more beneficial in standard kidney than in extended donor recipients.Transplantation2009https://conductscience.org/library/papers/19424038PubMed

See all 56 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40429403

GET https://conductscience.org/api/papers/v1/40429403/references?page=2